Charles Schwab Investment Management Inc United Therapeutics Corp Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 370,540 shares of UTHR stock, worth $133 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
370,540
Previous 369,955
0.16%
Holding current value
$133 Million
Previous $133 Million
1.38%
% of portfolio
0.02%
Previous 0.03%
Shares
30 transactions
Others Institutions Holding UTHR
# of Institutions
723Shares Held
60.9MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$6.56 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.59 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$989 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$883 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...